Grufity logoGrufity logo

agilon health, inc. Stock Research

AGL

26.08USD+2.17(+9.08%)Delayed

Market Summary

USD26.08+2.17
Delayed
9.08%

AGL Alerts

AGL Stock Price

AGL RSI Chart

AGL Valuation

Market Cap

10.8B

Price/Earnings (Trailing)

-100.94

Price/Sales (Trailing)

3.97

EV/EBITDA

-117.26

Price/Free Cashflow

-73.55

AGL Price/Sales (Trailing)

AGL Profitability

EBT Margin

-3.90%

Return on Equity

-10.24%

Return on Assets

-6.28%

Free Cashflow Yield

-1.36%

AGL Fundamentals

AGL Revenue

Revenue (TTM)

2.7B

Revenue Y/Y

49.02%

Revenue Q/Q

-0.73%

AGL Earnings

Earnings (TTM)

-106.6M

Earnings Y/Y

0.45%

Earnings Q/Q

-84.12%

Price Action

52 Week Range

14.8228.36
(Low)(High)

Last 7 days

-2.2%

Last 30 days

4.6%

Last 90 days

39.0%

Trailing 12 Months

21.1%

AGL Financial Health

Current Ratio

2.71

Debt/Equity

0.04

Debt/Cashflow

-3.11

AGL Investor Care

Shares Dilution (1Y)

3.07%

Financials for agilon health

Income Statement (Last 12 Months)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Revenue9.1%2,708,211,0002,481,323,0002,245,078,0002,073,900,0001,833,559,000
Operating Expenses9.6%2,828,642,0002,580,509,0002,350,347,0002,456,480,0002,227,511,000
  S&GA Expenses10.8%218,945,000197,578,000192,241,000457,878,000455,821,000
EBITDA2.7%-87,392,000-89,852,000-96,313,000-371,657,000-
EBITDA Margin10.9%-0.03-0.04-0.04-0.18-
Earnings Before Taxes1.2%-105,689,000-106,994,000-113,787,000-390,223,000-404,598,000
EBT Margin9.5%-0.04-0.04-0.05-0.19-
Interest Expenses23.8%4,525,0003,656,0003,523,0004,076,0006,146,000
Net Income0.2%-106,553,000-106,808,000-111,983,000-390,179,000-406,487,000
Net Income Margin8.6%-0.04-0.04-0.05-0.19-
Free Cahsflow-0.8%-146,234,000-145,083,000-165,958,000-140,999,000-
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Assets-9.2%1,6971,8701,8411,8551,586
  Current Assets-11.2%1,4511,6341,6011,6281,367
    Cash Equivalents-7.9%5085516691,0221,040
  Net PPE11.8%20.0018.0016.0013.009.00
  Goodwill0%42.0042.0042.0042.0042.00
Liabilities-16.3%657785737744495
  Current Liabilities-18.7%535658605610357
  Long Term Debt-49.00----
    LT Debt, Current0%5.005.005.005.005.00
    LT Debt, Non Current-3.1%38.0040.0041.0042.0043.00
Shareholder's Equity-4.2%1,0411,0861,1031,1111,092
  Retained Earnings-5.6%-1,064-1,007-977-956-957
  Additional Paid-In Capital0.6%2,1072,0952,0762,0642,046
Accumulated Depreciation-12.4%8.009.008.00--
Shares Outstanding0.2%412412408406400
Minority Interest-15.7%-0.61-0.53-0.46-0.37-0.30
Cashflow (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Cashflow From Operations-0.8%-130-129-151-130-148
  Share Based Compensation24.2%28.0023.0027.00295292
Cashflow From Investing-1.2%-444-439-319-90.30-90.51
Cashflow From Financing-24.9%28.0037.0029.001,1381,154
  Buy Backs-0.00----

Risks for AGL

What is the probability of a big loss on AGL?

87.1%


Probability that agilon health stock will be more than 20% underwater in next one year

78.2%


Probability that agilon health stock will be more than 30% underwater in next one year.

75.3%


Probability that agilon health stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does AGL drawdown profile look like?

Y-axis is the maximum loss one would have experienced if agilon health was unfortunately bought at previous high price.

Drawdowns

Returns for AGL

Cumulative Returns on AGL

Which funds bought or sold AGL recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-03-10
VICTORY CAPITAL MANAGEMENT INC
reduced
-0.05
-173,110
383,890
-%
2023-03-06
Rockefeller Capital Management L.P.
reduced
-97.19
-18,000
-
-%
2023-02-28
Voya Investment Management LLC
added
-
-544,663
1,207,340
-%
2023-02-27
Parallax Volatility Advisers, L.P.
reduced
-99.39
-727,933
3,067
-%
2023-02-24
NATIXIS
sold off
-100
-812,000
-
-%
2023-02-21
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO
new
-
32.00
32.00
-%
2023-02-21
MACQUARIE GROUP LTD
sold off
-100
-144,000
-
-%
2023-02-15
ALLIANCEBERNSTEIN L.P.
reduced
-32.17
-1,347,150
1,182,850
-%
2023-02-15
JANE STREET GROUP, LLC
new
-
2,023,880
2,023,880
-%
2023-02-15
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO
added
2.14
-658,000
1,564,000
0.01%

1–10 of 46

Latest Funds Activity

Are funds buying AGL calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own AGL
No. of Funds

agilon health News

Nasdaq

Guru Fundamental Report for AGL - Benjamin Graham.

Nasdaq,
2 hours ago

Seeking Alpha

Schedule 13G FIlings of agilon health

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Mar 10, 2023
capital world investors
10.3%
42,425,420
SC 13G/A
Feb 13, 2023
capital world investors
9.2%
37,918,473
SC 13G/A
Feb 08, 2023
morgan stanley
9.1%
37,574,546
SC 13G/A
Feb 06, 2023
wellington management group llp
5.52%
22,745,297
SC 13G
Jan 10, 2023
fmr llc
-
0
SC 13G/A
Feb 14, 2022
cd&r vector holdings, l.p.
52.3%
205,948,808
SC 13G
Feb 11, 2022
capital world investors
9.1%
35,865,953
SC 13G
Feb 09, 2022
fmr llc
-
0
SC 13G

AGL Fair Value

agilon health fair value in different scenarios

The table shows the Fair Value estimates for agilon health for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
Fair ValueVery PessimisticPessimisticBase CaseOptimisticVery Optimistic
Very Low Inflation

1.75

-93.29%

3.10

-88.11%

7.55

-71.05%

15.49

-40.61%

31.29

19.98%
Current Inflation

1.65

-93.67%

2.86

-89.03%

6.74

-74.16%

13.57

-47.97%

27.08

3.83%
Very High Inflation

1.53

-94.13%

2.57

-90.15%

5.79

-77.80%

11.33

-56.56%

22.21

-14.84%

Historical agilon health Fair Value Estimates


Very Pessimistic Case
Pessimistic Case
Fair Value
Optimistic Case
Very Optimistic Case
Closing Stock Price

Recent SEC filings of agilon health

View All Filings
Date Filed Form Type Document
Mar 10, 2023
SC 13G/A
Major Ownership Report
Mar 09, 2023
4
Insider Trading
Mar 01, 2023
10-K
Annual Report
Mar 01, 2023
8-K
Current Report
Feb 22, 2023
8-K
Current Report
Feb 22, 2023
4
Insider Trading
Feb 22, 2023
3
Insider Trading
Feb 16, 2023
4
Insider Trading
Feb 16, 2023
4
Insider Trading
Feb 13, 2023
SC 13G/A
Major Ownership Report

Latest Insider Trading transactions for AGL

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-03-08
Kornitzer Benjamin
acquired
72,765
8.99
8,094
chief med. & quality officer
2023-03-08
Kornitzer Benjamin
sold
-197,821
24.4404
-8,094
chief med. & quality officer
2023-03-07
Kornitzer Benjamin
sold
-197,197
24.3634
-8,094
chief med. & quality officer
2023-03-07
Kornitzer Benjamin
acquired
72,765
8.99
8,094
chief med. & quality officer
2023-02-17
MCKENZIE DIANA
acquired
-
-
1,078
-
2023-02-15
Shaker Benjamin
acquired
28,555
1.00
28,555
chief markets officer
2023-02-15
Shaker Benjamin
sold
-667,342
23.3704
-28,555
chief markets officer
2023-02-15
Kornitzer Benjamin
acquired
72,765
8.99
8,094
chief med. & quality officer
2023-02-15
Kornitzer Benjamin
sold
-186,028
22.9834
-8,094
chief med. & quality officer
2023-02-14
Kornitzer Benjamin
sold
-594,877
22.9851
-25,881
chief med. & quality officer

1–10 of 50

Steven J. Sell
650
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.

AGL Income Statement

2022-12-31
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Revenues:   
Total revenues$ 2,708,211$ 1,833,559$ 1,218,333
Expenses:   
Medical services expense2,399,7981,647,6591,021,877
Other medical expenses196,127109,487102,306
General and administrative218,945455,821137,292
Depreciation and amortization13,77214,54413,531
Total expenses2,828,6422,227,5111,275,006
Income (loss) from operations(120,431)(393,952)(56,673)
Other income (expense):   
Other income (expense), net24,725(4,500)2,465
Gain (loss) on lease terminations(5,458)00
Interest expense(4,525)(6,146)(8,135)
Income (loss) before income taxes(105,689)(404,598)(62,343)
Income tax benefit (expense)(1,640)(886)(865)
Income (loss) from continuing operations(107,329)(405,484)(63,208)
Discontinued operations:   
Income (loss) before impairments, gain (loss) on sales and income taxes491(3,463)(20,049)
Gain (loss) on sales of assets, net047320,401
Income tax benefit (expense)(26)1,6872,804
Total discontinued operations465(1,303)3,156
Net income (loss)(106,864)(406,787)(60,052)
Noncontrolling interests' share in (earnings) loss3113000
Net income (loss) attributable to common shares$ (106,553)$ (406,487)$ (60,052)
Net income (loss) per common share, basic and diluted   
Net income (loss) per common share from continuing operations basic and diluted$ (0.26)$ (1.09)$ (0.20)
Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share000.01
Income (Loss) from Continuing Operations, Per Diluted Share(0.26)(1.09)(0.20)
Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share$ 0$ 0$ 0.01
Weighted Average Number of Shares Outstanding, Basic408,154372,931323,462
Weighted Average Number of Shares Outstanding, Diluted408,154372,931323,462
Medical Services Revenue   
Revenues:   
Total revenues$ 2,704,396$ 1,829,735$ 1,214,270
Other Operating Revenue   
Revenues:   
Total revenues$ 3,815$ 3,824$ 4,063

AGL Balance Sheet

2022-12-31
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets:  
Cash and cash equivalents$ 497,070$ 1,040,039
Restricted cash and equivalents10,61014,781
Marketable securities411,9010
Receivables, net497,574293,407
Prepaid expenses and other current assets, net34,11918,968
Total current assets1,451,2741,367,195
Property and equipment, net20,0509,161
Intangible assets, net67,68055,398
Goodwill41,54041,540
Other assets, net116,924112,958
Total assets1,697,4681,586,252
Current liabilities:  
Medical claims and related payables346,727239,014
Accounts payable and accrued expenses183,364112,946
Current portion of long-term debt5,0005,000
Total current liabilities535,091356,960
Long-term debt, net of current portion38,48243,401
Other liabilities83,28694,295
Total liabilities656,859494,656
Commitments and contingencies
Stockholders' equity (deficit):  
Common stock, $0.01 par value: 2,000,000 shares authorized; 412,385 and 400,095 shares issued and outstanding, respectively4,1244,001
Additional paid-in capital2,106,8862,045,572
Accumulated deficit(1,064,230)(957,677)
Accumulated other comprehensive income (loss)(5,560)0
Total agilon health, inc. stockholders' equity (deficit)1,041,2201,091,896
Noncontrolling interests(611)(300)
Total stockholders’ equity (deficit)1,040,6091,091,596
Total liabilities and stockholders' equity (deficit)$ 1,697,468$ 1,586,252